Adri­an Hay­day re­futes chal­lenge on in­flu­en­tial au­toan­ti­body pa­per by Karolin­s­ka sci­en­tists

Back in 2016, Adri­an Hay­day and his col­leagues at King’s Col­lege Lon­don — to­geth­er with some col­lab­o­ra­tors in Ger­many and Es­to­nia — made a splash in the im­munol­o­gy world with a pa­per, pub­lished in Cell, sug­gest­ing that pa­tients with a par­tic­u­lar ge­net­ic de­fect pro­duce more au­toan­ti­bod­ies than pre­vi­ous­ly known. These self-gen­er­at­ed an­ti­bod­ies, they pro­posed, of­fered ther­a­peu­tic po­ten­tial for au­toim­mune dis­eases, most promi­nent­ly Type 1 di­a­betes.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER